<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04006951</url>
  </required_header>
  <id_info>
    <org_study_id>ICM-BCB-2014/02</org_study_id>
    <nct_id>NCT04006951</nct_id>
  </id_info>
  <brief_title>Development of a Clinical and Biological Database in Rectum Cancer</brief_title>
  <acronym>BCBRectum</acronym>
  <official_title>Development of a Monocentric and Prospective Clinical and Biological Database in Rectum Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut du Cancer de Montpellier - Val d'Aurelle</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut du Cancer de Montpellier - Val d'Aurelle</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Clinical and Biological Database will provide to the scientific community a collection of&#xD;
      blood and tissues with clinical data to improve knowledge about cancer and help to develope&#xD;
      new cancer treatments. This database is specific to Rectum Cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In France, colorectal cancer is the second major cause of cancer-related death with 17 000&#xD;
      cases per year. Rectal carcinoma represents 40% of colorectal cancers.&#xD;
&#xD;
      Locally advanced rectal carcinoma raises the issue of both the oncological control, local and&#xD;
      general, and the therapeutic morbidity. Currently, pre-operative radiochemotherapy associated&#xD;
      with radical proctectomy (TME) is the standard treatment. Radiochemotherapy improves the&#xD;
      local control but with enhanced postoperative morbidity and poor functional results.&#xD;
&#xD;
      Moreover, some patients have no downstaging (around 1/3) and the metastatic risk remains&#xD;
      about 30%.&#xD;
&#xD;
      Then, compliance to adjuvant chemotherapy is generally poor after radical proctectomy.&#xD;
&#xD;
      Tumor response to preoperative treatment is the major prognostic factor which reveals tumor&#xD;
      aggressiveness. Nevertheless, at present, there are no predictive markers of tumor response.&#xD;
&#xD;
      Progresses in rectal cancer management are related to sharing biological and clinical&#xD;
      resources with scientific community.&#xD;
&#xD;
      A clinical and biological collection will allow to :&#xD;
&#xD;
        -  develop research programs on predictive markers to pre-operative radiochemotherapy or&#xD;
           prognostics factors to disease recurrence&#xD;
&#xD;
        -  optimize diagnostic and follow-up tests&#xD;
&#xD;
        -  develop new biomarkers to improve patient's therapeutic management&#xD;
&#xD;
      In this context, the Montpellier Cancer Institute (ICM) decided to initiate a biological&#xD;
      collection biomedical research dedicated to the tissular and blood samples of patients with&#xD;
      colorectal cancer.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 8, 2014</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">July 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of patients who gave their consent to participate in the study</measure>
    <time_frame>Until the study completion : 66 months</time_frame>
    <description>The proportion of patients who consent to participate in the study among the screened patients</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Rectal Neoplasms</condition>
  <arm_group>
    <arm_group_label>Biological collection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For all the patients include in the study :&#xD;
Paraffin tissue samples (if applicable) collected during pre-therapeutic rectal biopsy&#xD;
Blood samples collected at different times : Before any treatment and Before surgery if the patient received pre-operative radiochemotherapy&#xD;
In parallel to this biological collection, standardized clinical data will be entered into a database</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Biological collection</intervention_name>
    <description>Blood samples are collected at different times :&#xD;
Before any treatment&#xD;
After pre-operative radiochemotherapy and before surgery (if applicable)</description>
    <arm_group_label>Biological collection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient treated at the Montpellier Cancer Institute, whatever the treatment received&#xD;
             (systemic cancer treatment or radiotherapy or surgery)&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient not affiliated to Social Protection system&#xD;
&#xD;
          -  Patient unable to understand or comply with study instructions or requirements for&#xD;
             psychological, family, social or geographical reasons&#xD;
&#xD;
          -  Patient under guardianship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ROUANET Philippe, MD-PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institut r√©gional du Cancer Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>BLEUSE Jean-Pierre, MD</last_name>
    <phone>4 67 61 31 00</phone>
    <phone_ext>+33</phone_ext>
    <email>jean-pierre.bleuse@icm.unicancer.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>ICM Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34298</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BLEUSE Jean-pierre</last_name>
      <phone>00467613102</phone>
      <email>jean-pierre.bleuse@icm.unicancer.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 1, 2019</study_first_submitted>
  <study_first_submitted_qc>July 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2019</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cancer</keyword>
  <keyword>Colorectal cancer</keyword>
  <keyword>Biological Specimen Banks</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

